Summary of Anticipated Changes to Annex 1
January 11, 2017
EU GMP Annex 1 on sterile product manufacturing is undergoing a major revision, which is being conducted jointly with PIC/S. This is a total re-write of this critical Annex. Whilst we have not had a formal draft published yet, we do now have a very good idea of the changes that will be in the draft when it is published, and of the areas of contention that are still being debated. This fish-bone diagram will provide you with the latest news regarding the revision of Annex 1, which will help sterile product producers prepare for the major changes that are coming.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Welcomes Mel Cash as Chief Commercial Officer
October 14, 2024Global public health and safety organisation announces new Commercial lead to drive growth and innovation.
Read the Story
NSF Spotlighted in “SDG Leaders” Series on CNBC.com
October 3, 2024The docuseries highlights businesses that are addressing core issues within the 17 United Nations (UN) Sustainable Development Goals (SDGs), offering a glimpse into what people can expect as these organisations strive to tackle existential challenges, embedding the sustainability goals at the heart of their work.
Read the Story
NSF Celebrates 80 Years of Improving Human and Planet Health
September 12, 2024NSF has been pioneering public and environmental health since 1944 by developing and implementing public and environmental health standards.
Read the Story
NSF To Host Pharma Compliance to Performance Conference
September 5, 2024NSF will host its 2nd pharmaceutical conference in London on November 14th, 2024.
Read the Story